Wolf CL - Search Results

1

OSM-induced CD44 contributes to breast cancer metastatic potential through cell detachment but not epithelial-mesenchymal transition.

Covert H, Mellor LF, Wolf CL, Ankenbrandt N, Emathinger JM, Tawara K, Oxford JT, Jorcyk CL. Covert H, et al. Among authors: wolf cl. Cancer Manag Res. 2019 Aug 15;11:7721-7737. doi: 10.2147/CMAR.S208721. eCollection 2019. Cancer Manag Res. 2019. PMID: 31496817 Free PMC article.

2

HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β.

Tawara K, Scott H, Emathinger J, Wolf C, LaJoie D, Hedeen D, Bond L, Montgomery P, Jorcyk C. Tawara K, et al. Oncotarget. 2019 Mar 12;10(21):2068-2085. doi: 10.18632/oncotarget.26699. eCollection 2019 Mar 12. Oncotarget. 2019. PMID: 31007849 Free PMC article.

3

Bioactive recombinant human oncostatin M for NMR-based screening in drug discovery.

Mass OA, Tuccinardi J, Woodbury L, Wolf CL, Grantham B, Holdaway K, Pu X, King MD, Warner DL, Jorcyk CL, Warner LR. Mass OA, et al. Among authors: wolf cl. Sci Rep. 2021 Aug 10;11(1):16174. doi: 10.1038/s41598-021-95424-6. Sci Rep. 2021. PMID: 34376712 Free PMC article.

4

The clinical relevance of OSM in inflammatory diseases: a comprehensive review.

Wolf CL, Pruett C, Lighter D, Jorcyk CL. Wolf CL, et al. Front Immunol. 2023 Sep 29;14:1239732. doi: 10.3389/fimmu.2023.1239732. eCollection 2023. Front Immunol. 2023. PMID: 37841259 Free PMC article. Review.

5

Nullomer peptide increases immune cell infiltration and reduces tumor metabolism in triple negative breast cancer mouse model.

Ali N, Wolf C, Kanchan S, Veerabhadraiah SR, Bond L, Turner MW, Jorcyk CL, Hampikian G. Ali N, et al. Among authors: wolf c. Res Sq [Preprint]. 2023 Jun 28:rs.3.rs-3097552. doi: 10.21203/rs.3.rs-3097552/v1. Res Sq. 2023. Update in: Biomed Pharmacother. 2024 Jan;170:115997. doi: 10.1016/j.biopha.2023.115997. PMID: 37461536 Free PMC article. Updated. Preprint.

6

9S1R nullomer peptide induces mitochondrial pathology, metabolic suppression, and enhanced immune cell infiltration, in triple-negative breast cancer mouse model.

Ali N, Wolf C, Kanchan S, Veerabhadraiah SR, Bond L, Turner MW, Jorcyk CL, Hampikian G. Ali N, et al. Among authors: wolf c. Biomed Pharmacother. 2024 Jan;170:115997. doi: 10.1016/j.biopha.2023.115997. Epub 2023 Dec 20. Biomed Pharmacother. 2024. PMID: 38118350 Free PMC article.

7

K252a, KT5720, KT5926, and U98017 support paclitaxel (taxol)-dependent cells and synergize with paclitaxel.

Abraham I, Wolf CL, Sampson KE, Laborde AL, Shelly JA, Aristoff PA, Skulnick HI. Abraham I, et al. Among authors: wolf cl. Cancer Res. 1994 Nov 15;54(22):5889-94. Cancer Res. 1994. PMID: 7954419

8

Staurosporine reduces P-glycoprotein expression and modulates multidrug resistance.

Sampson KE, Wolf CL, Abraham I. Sampson KE, et al. Among authors: wolf cl. Cancer Lett. 1993 Jan 15;68(1):7-14. doi: 10.1016/0304-3835(93)90213-s. Cancer Lett. 1993. PMID: 8093679

9

Non-glucocorticoid steroid analogues (21-aminosteroids) sensitize multidrug resistant cells to vinblastine.

Abraham I, Wolf CL, Sampson KE. Abraham I, et al. Among authors: wolf cl. Cancer Chemother Pharmacol. 1993;32(2):116-22. doi: 10.1007/BF00685613. Cancer Chemother Pharmacol. 1993. PMID: 8097968

10

Pathologic quiz case 1. Chondroid syringoma.

Wolf CL, Breen DL, Dudrey EF. Wolf CL, et al. Arch Otolaryngol Head Neck Surg. 1988 May;114(5):574-6. Arch Otolaryngol Head Neck Surg. 1988. PMID: 2833291 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page